Home / BALPHARMA.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does BALPHARMA.NS make money? Does BALPHARMA.NS have pricing power? What's the Earnings Whisper? Will BALPHARMA.NS profit more as the business scales? What is BALPHARMA.NS's management track record? Is BALPHARMA.NS's current price justified?

Bal Pharma Limited

₹95.75 +$22.73 (+31.13%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹97.74

Day Range

₹95.15₹99

Year Range

₹60₹124.6

Market Cap

1.52B

AVG Volume

63.57K

Trailing/Forward PE

21.09/-

PEG ratio

-3.4

Dividend Yield

1.25%

Next Earnings Date

Primary Exchange

National Stock Exchange of India

Revenue (INR) · A

BALPHARMA.NS Revenue (INR) by year
Period	Revenue (INR)
2026	3.12B
2025	3.03B
2024	3.39B
2023	3.04B
2022	2.81B
2021	2.51B
2020	1.71B
2019	2.2B
2018	2.12B
2017	2.34B

Net Income (INR) · A

BALPHARMA.NS Net Income (INR) by year
Period	Net Income (INR)
2026	62.83M
2025	72.16M
2024	85.03M
2023	25.74M
2022	56.39M
2021	47.42M
2020	-122.18M
2019	53.57M
2018	1.21M
2017	19.86M

Operating Income (INR) · A

BALPHARMA.NS Operating Income (INR) by year
Period	Operating Income (INR)
2026	208.24M
2025	197.9M
2024	228.56M
2023	166.91M
2022	145.1M
2021	170.88M
2020	-26.12M
2019	119.51M
2018	110.78M
2017	108.46M

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (INR) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Bal Pharma Limited

Video analysis: BALPHARMA.NS

News: BALPHARMA.NS

Similar companies